
Rabaze-D Tablet
Marketer
Agex Laboratories Pvt Ltd
Salt Composition
Domperidone (10mg) + Rabeprazole (20mg)
Overview Rabaze-D Tablet
Gastro-Ease combines medications to alleviate gastroesophageal reflux disease (GERD), commonly known as acid reflux. It targets heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion. Dosage and duration for Gastro-Ease are determined by your physician and depend on individual response and condition; consistent use as prescribed is crucial to prevent symptom recurrence and disease progression. Inform your doctor of all other medications, as interactions may occur. Common, generally transient, side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or activities requiring alertness until effects are known. Alcohol should be avoided due to increased drowsiness risk. Dietary adjustments, such as consuming cool milk and avoiding caffeine, spicy foods, and chocolate, can enhance treatment. Prior to commencing treatment, inform your doctor of any kidney or liver conditions, or if you are pregnant, planning pregnancy, or breastfeeding.
Uses of Rabaze-D Tablet
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Rabaze-D Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Rabaze-D Tablet on an empty stomach.
Common Side effects of Rabaze-D Tablet:
- Pharyngitis
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Insomnia (difficulty in sleeping)
- Nausea
- Constipation
- Flatulence
- Nasal congestion (stuffy nose)
- Fundic gland polyps
- Back pain
How to use Rabaze-D Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rabaze-D Tablets should be administered on an empty stomach.
How Rabaze-D Tablet works:
Rabaze-D tablets contain Domperidone and Rabeprazole, acting synergistically to manage digestive issues. Domperidone, a prokinetic agent, enhances gastrointestinal motility, facilitating smoother food passage. Rabeprazole, a proton pump inhibitor (PPI), diminishes stomach acid production, providing relief from acid reflux and heartburn.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Rabaze-D Tablet and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Rabaze-D Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Use of Rabaze-D Tablet while breastfeeding is likely inadvisable. Preliminary human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Rabaze-D tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Rabaze-D Tablets. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Rabaze-D Tablets, potentially requiring dose modification. A physician's consultation is advised. Rabaze-D Tablets are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Rabaze-D Tablet :
Should you forget a Rabaze-D Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rabaze-D Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal System |
